REDUCTION OF DIABETIC CARDIOVASCULAROPATHY BY AMINOGUANIDINE
氨基胍减少糖尿病心血管病
基本信息
- 批准号:06670683
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
a.In rat with insulin-dependent diabetes mellitus (IDDM) acetylcholin-induced endothelium-dependent hyperpolarization and relaxation mediated by endothelium-derived hyperpolarizing factor (EDHF) were impaired. Accumulation of advanced glycosylation endproduct (AGE) generated in hyperglycemia was not thought to result in the impaired EDHF function.b.In IDDM heart lining of capillary vessels was disorientated. The microvascular disorientation was thought to derive from hyperfibrinolytic state due to low plasminogen activator inhibitor-1 (PAI-1) resulting from insulin deficiency. AGE was not thought to be related to the microvasculopathy.c.Bradykinin-induced dilatation of coronary vascular beds mediated by endothelium-derived relaxing factor (EDRF), but not that by EDHF,was impaired. The impaired EDRF function was reduced by normalizing hyperfibrinolysis and the resultant microvasculular disorientation with irsogladine.Thus, it was revealed that microvasculopathy such as microvascular disorientation and EDRF mulfunction exists in the IDDM heart. The mechanisms of microvasculopathy were presumably related to hyperfibrinolysis resutling from low PAI-1 ; since we had found in vitro that insulin increases PAI-1 protein in cultured rat coronary capillary endothelial cells, the lack of insulin in IDDM could lead to low PAI-1 in coronary microvessels in vivo. In the next step to clarify the hypothesis, the relationship among insulin, PAI-1 and tissue plasminogen activator should be investigated further in detail. In addition, in the present study irsogladine, a clinically available antiulcer drug, inhibited the microvasculopathy. If the inhibition of microvasculopathy improves cardiac function in IDDM heart, irsogladine may be clinically of great value.
在胰岛素依赖型糖尿病(insulin-dependent diabetes mellitus,IDDM)大鼠,乙酰胆碱诱导的内皮依赖性超极化和内皮源性超极化因子(endothelium-derived hyperpolarizing factor,EDHF)介导的舒张功能受损。高血糖时产生的晚期糖基化终产物(AGE)的积累不被认为是导致EDHF功能受损的原因。B.在IDDM中,毛细血管的心脏衬里被打乱。微血管定向障碍被认为是由于胰岛素缺乏导致纤溶酶原激活物抑制物-1(派-1)水平降低而导致纤溶亢进。AGE被认为是不相关的微血管病变。c.缓激肽诱导的扩张冠状动脉血管床介导的内皮源性舒张因子(EDRF),但不是由EDHF,受损。用Irsogladine使纤维蛋白溶解亢进和微血管定向障碍正常化,从而使受损的EDRF功能降低,从而揭示了微血管病变如微血管定向障碍和EDRF功能障碍在IDDM心脏中的存在。微血管病变的发生机制可能与派-1水平降低导致纤溶功能亢进有关,由于我们在体外培养的大鼠冠状动脉毛细血管内皮细胞中发现胰岛素可增加派-1蛋白,因此在体内实验中,胰岛素缺乏可导致IDDM患者冠状动脉微血管派-1水平降低。在下一步阐明这一假说时,胰岛素、派-1和组织型纤溶酶原激活剂之间的关系应进一步详细研究。此外,在本研究中,临床上可用的抗溃疡药物irsogladine可抑制微血管病变。如果微血管病变的抑制能改善胰岛素依赖型糖尿病心脏的心功能,伊索拉定可能具有重要的临床价值。
项目成果
期刊论文数量(96)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takehiro Yamashita et al.: "Depressed responsiveness to angiotensin II in ventricular myocytes of bypertrophic cardiomyopathic Syrian hamster." J Mol Cell Cardiol. 26. 1429-1438 (1994)
Takehiro Yamashita 等人:“肥厚型心肌病叙利亚仓鼠心室肌细胞对血管紧张素 II 的反应性降低。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mitsuhiro Fukao et al.: "Structural defferences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric artery" Biochem Biophys Res Commun. 227. 479-483 (1996)
Mitsuhiro Fukao 等人:“大鼠肠系膜动脉中溶血磷脂抑制乙酰胆碱依赖的内皮细胞超极化能力的结构差异”Biochem Biophys Res Commun。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Michio Hashimoto et al.: "Note on the acetylcholine-induced relaxation of porcine coronary arteries" Life Sciences. 54. 525-531 (1994)
Michio Hashimoto 等人:“关于乙酰胆碱诱导的猪冠状动脉松弛的注意事项”生命科学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mitsuhiro Fukao et al.: "Thapsigargin-and cyclopiazonic acid-induced eudothelium-dependeut hyperpolarization in rat mesenteric artery." British Journal of Pharwacology. 115. 987-992 (1995)
Mitsuhiro Fukao 等人:“毒胡萝卜素和环吡嗪酸诱导大鼠肠系膜动脉内皮依赖性超极化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Risa Korenaga: "Laminar flow stimulates ATP-and shear stress-dependent nitric oxide production in cultured bovine endothelial cells." Biochem Biophys Res Commun. 198. 213-219 (1994)
Risa Korenaga:“层流刺激培养的牛内皮细胞中 ATP 和剪切应力依赖性一氧化氮的产生。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAKUMA Ichiro其他文献
Partial blockade of IK_1 destabilizes the rotation center of spiral wave reentry without enhancement of wavefront-tail interaction in the arm
部分封锁 IK_1 会破坏螺旋波折返旋转中心的稳定性,而不会增强手臂中的波前-尾部相互作用
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
KUSHIYAMA Yasunori;HONJO Haruo;NIWA Ryoko;TAKANARI Hiroki;YAMAZAKI Masatoshi;TAKEMOTO Yoshio;UEDA Norihiro;OKUNO Yusuke;SAKUMA Ichiro;KODAMA Itsuo;KAMIYA Kaichiro - 通讯作者:
KAMIYA Kaichiro
SAKUMA Ichiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAKUMA Ichiro', 18)}}的其他基金
Reconstruction of three dimensional excitation propagation waveform in heart wall from two dimensional optical mapping data
从二维光学映射数据重建心壁三维激励传播波形
- 批准号:
24300159 - 财政年份:2012
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cardiac action potential and Ca2+ ion simultaneous dual measurement and temporal and spatial high resolution optical mapping system
心脏动作电位和Ca2离子同时双测量及时空高分辨率光学测绘系统
- 批准号:
20500387 - 财政年份:2008
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation system of cardiac cells and tissues with combined micro-electrode array based electrical mapping and optical mapping system
基于组合微电极阵列的电测绘和光学测绘系统的心脏细胞和组织评估系统
- 批准号:
16200033 - 财政年份:2004
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A RESERACH ON DEVELOPMENT AND APPLICATION OF THE CLINICALLY APPRICABLE NEW ARTIFICIALRED BLOOD CELLAND ARTIFICIAL OXYGEN CARRIER
临床适用的新型人工红细胞和人工氧载体的开发及应用研究
- 批准号:
14370479 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
OPTICAL MAPPING SYSTEM WITH DUAL HIGH SPEED VIDEO CAMERAS FOR OBSERVATION OF THREE DIMENSIONAL CARDIAC EXCITATION PROPAGATION DURING ARRHYTHMIA
具有双高速摄像机的光学绘图系统,用于观察心律失常期间的三维心脏兴奋传播
- 批准号:
14380392 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
High spatial-temporal resolution optical mapping of cardiac membrane action potentials using high intensity light emitting diodes and high spee3 digital video cameras
使用高强度发光二极管和高速数字摄像机对心脏膜动作电位进行高时空分辨率光学测绘
- 批准号:
12680825 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study forthe effects of estrogen on actions ofendothelium-derived hyperpolarizing factor
雌激素对内皮源性超极化因子作用影响的研究
- 批准号:
11470342 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study on the development and application of clinically available new artificial bloods and artificial oxygen carriers
临床新型人造血液和人工氧载体的开发及应用研究
- 批准号:
11557112 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DEVELOPMENT OF EFFICIENT PRODUCTION SYSTEM OF TRANSGENIC MINIPIG
转基因小型猪高效生产体系的开发
- 批准号:
11358015 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
相似海外基金
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6567745 - 财政年份:2001
- 资助金额:
$ 1.41万 - 项目类别:
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6566158 - 财政年份:2001
- 资助金额:
$ 1.41万 - 项目类别:
The study of the mechanism of cataract formation using aminoguanidine, which has the ability to prevent lens opacification.
利用氨基胍研究白内障形成机制,氨基胍具有防止晶状体混浊的能力。
- 批准号:
12670150 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6468485 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6504306 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6423329 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
Neuartige semicyclische Aminoguanidine als Inhibitoren der Stickstoffmonoxid-vermittelten Schädigung isolierter Pankreasinseln
新型半环氨基胍作为一氧化氮介导的离体胰岛损伤的抑制剂
- 批准号:
5208638 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Research Grants
PLACEBO CONTROLLED SAFETY/EFFICACY STUDY OF AMINOGUANIDINE IN DIABETIC PATIENTS
氨基胍在糖尿病患者中的安慰剂对照安全性/有效性研究
- 批准号:
6219250 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6297317 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
- 批准号:
6117661 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:














{{item.name}}会员




